Lufenuron

Insect Growth Regulator (IGR) Benzoylurea

Dosage & Administration Guidelines

Species Route Dose Frequency Duration & Clinical Notes
Dog PO 10 mg/kg Once monthly Duration: Continuous during flea season or as needed
Notes: Administer with food to enhance absorption. For optimal control, combine with an adulticide to kill existing adult fleas.
Cat PO 10 mg/kg Once monthly Duration: Continuous during flea season or as needed
Notes: Administer with food. Safe for kittens over 6 weeks of age.
Cattle PO 5 mg/kg Once monthly Duration: As needed for flea and lice control
Notes: Not approved in all countries; check local regulations. Withdrawal times must be observed.

Clinical Indications & Species Uses

General Indications
  • Prevention of flea reproduction and environmental flea control
Dog (Canine)
  • Prevention and control of flea infestations (Ctenocephalides felis and Ctenocephalides canis)
Cat (Feline)
  • Prevention and control of flea infestations (Ctenocephalides felis)
Cattle (Bovine)
  • Control of fleas and lice (in some countries, but not approved in all regions)

Pharmacology & Mechanism of Action

Drug Class: Insect Growth Regulator (IGR) | Pharmacological Group: Benzoylurea

Mechanism of Action: Lufenuron is a benzoylurea insect growth regulator that inhibits chitin synthesis in insects. It is absorbed systemically and deposited in the fat tissue of the treated animal. When fleas ingest blood from the animal, they absorb lufenuron, which is then transferred to the developing flea eggs. Lufenuron interferes with the formation of chitin in the eggshell, preventing the eggs from hatching. It does not kill adult fleas but breaks the flea life cycle by preventing the development of new generations.

Pharmacodynamics: Lufenuron is highly lipophilic and accumulates in the adipose tissue of the treated animal. It is slowly released into the bloodstream, providing a sustained concentration that is effective against fleas. The drug is more effective against immature stages of fleas (eggs and larvae) than adults. It has no effect on adult fleas, ticks, mites, or other arthropods. The onset of action is slow, and it may take several weeks to reduce flea populations in the environment.

⚡ Pharmacokinetics Summary

Absorption: Lufenuron is poorly absorbed from the gastrointestinal tract. Oral bioavailability is low (approximately 10-20%) in dogs and cats. It is absorbed more efficiently when given with a fatty meal. After absorption, it is distributed widely in the body, with high concentrations in adipose tissue.
Distribution: Lufenuron is highly lipophilic and distributes extensively into body fat. It crosses the placenta and is excreted in milk. It also accumulates in the skin and sebaceous glands, which contributes to its long-lasting effect.
Metabolism: Lufenuron is metabolized in the liver to a limited extent. The primary metabolic pathway involves hydroxylation and conjugation. The metabolites are not pharmacologically active.
Excretion: Lufenuron is excreted primarily in the feces via biliary excretion. A small amount is excreted in the urine. Because of its lipophilic nature, it has a long elimination half-life, especially in adipose tissue.
Half-Life: Dogs: approximately 30 days; Cats: approximately 30 days; Cattle: approximately 30 days (based on studies).
Bioavailability: Oral bioavailability is low (10-20%) in dogs and cats, but it is enhanced when administered with food (especially high-fat meals).
Protein Binding: Lufenuron is highly protein-bound (>99%) in plasma.

Available Formulations & Strengths

Oral Tablet 50 mg, 100 mg, 200 mg, 400 mg, 800 mg (PO)
Oral Suspension 50 mg/mL (PO)
Injectable Solution (for cattle, in some countries) 100 mg/mL (SC)

Contraindications & Clinical Warnings

Contraindications:
  • Hypersensitivity to lufenuron or any component of the formulation
  • Do not use in animals with known allergy to benzoylurea compounds
  • Not recommended for use in puppies or kittens under 6 weeks of age (safety not established)
  • Do not use in food animals unless specifically approved and withdrawal times are followed
Warnings & Clinical Precautions:
  • Lufenuron does not kill adult fleas; use in conjunction with an adulticide for rapid flea control.
  • In cases of heavy flea infestation, environmental control measures (e.g., vacuuming, washing bedding) are recommended.
  • Use with caution in pregnant or lactating animals; safety has not been fully established, but studies suggest it is safe.
  • For oral administration, ensure the animal swallows the full dose; if vomiting occurs, re-dose as needed.
  • In cattle, observe withdrawal times for meat and milk.
  • Keep out of reach of children and pets.

Adverse Effects & Reactions

Common:

  • Gastrointestinal upset (vomiting, diarrhea)
  • Loss of appetite
  • Lethargy

Serious / Severe:

  • Allergic reactions (facial swelling, hives, anaphylaxis)
  • Neurological signs (rare)

Rare:

  • Hepatotoxicity (reported in some cases)
  • Bone marrow suppression (very rare)

Key Drug Interactions

Interacting Drug / Class Clinical Effect & Mechanism Severity
Other flea control products (e.g., fipronil, imidacloprid) Additive effects in flea control; no adverse interactions reported. Mild
Lipophilic drugs (e.g., ivermectin, selamectin) Potential competition for plasma protein binding, but no clinically significant interactions reported. Mild
Corticosteroids May alter immune response, but no direct interaction with lufenuron. Mild

Overdose & Toxicity Management

Signs of Toxicity:

  • Gastrointestinal upset (vomiting, diarrhea)
  • Salivation
  • Depression
  • Incoordination (rare)

Emergency Treatment Protocol: Treatment is symptomatic and supportive. Induce vomiting if ingestion is recent and the animal is conscious. Administer activated charcoal to reduce absorption. Provide fluid therapy and supportive care as needed. There is no specific antidote.

Food Animal Withdrawal Times

🥩 Meat: 0 days🥛 Milk: 0 days

Lufenuron is not approved for use in food animals in many countries. In cattle, if used extra-label, withdrawal times may be required; consult local regulations. In the US, no withdrawal times are established for lufenuron in food animals.

Storage, Handling & Regulatory Information

Storage Temperature: Store at controlled room temperature 20-25°C (68-77°F), with excursions permitted between 15-30°C (59-86°F).

Handling & Special Conditions: Protect from moisture. Keep container tightly closed.

Dispensing Status: Over-The-Counter (OTC)

Approval Status: Approved by FDA for use in dogs and cats for flea control. Not approved for food animals in the US.

Extra-Label (Off-Label) Use: In the US, lufenuron is available over-the-counter for dogs and cats. Extra-label use in food animals is prohibited unless a valid veterinarian-client-patient relationship exists and withdrawal times are observed. In some countries, lufenuron is approved for use in cattle; check local regulations.

Clinical Pearls & Practice Notes

💡 Clinical Insights: Lufenuron is a safe and effective insect growth regulator for the prevention of flea infestations in dogs and cats. It is not an adulticide, so it should be used in combination with an adulticide (e.g., fipronil, imidacloprid, or spinosad) for rapid flea control. Lufenuron is administered orally once monthly, and its efficacy is enhanced when given with a fatty meal. It is particularly useful in households with multiple pets and for long-term flea prevention. In cattle, lufenuron may be used for flea and lice control in some countries, but its use is limited. Always follow label instructions and consult a veterinarian for appropriate use, especially in pregnant or lactating animals.

References & Literature

  • 📚 Plumb's Veterinary Drug Handbook
  • 📚 Papich Veterinary Pharmacology and Therapeutics
  • 📚 Compendium of Veterinary Products (CVP)